Literature DB >> 17966755

Cardioprotective effect of ocotillol, a derivate of pseudoginsenoside F11, on myocardial injury induced by isoproterenol in rats.

Chen Yu1, Fenghua Fu, Xin Yu, Bing Han, Mei Zhu.   

Abstract

PURPOSE: To investigate whether ocotillol, a derivate of pseudoginsenoside F11, might protect the heart against myocardial injury (MI) induced by isoproterenol (CAS 7683-59-2, ISO) in rats.
METHODS: Male Sprague-Dawley rats were administered orally (5, 10 and 20 mg kg(-1)) for 8 days. During the last two days all animals except the normal control were administered ISO, 50 mg kg(-1) subcutaneously, for 2 consecutive days to induce myocardial injury. 8 h later, rats were anaesthetized and sacrificed. The biochemical parameters were assayed and pathological examination of the heart tissues was performed. RESULT: Ocotillol could significantly decrease the increased level of lactate dehydrogenase (LDH) in animals with myocardial injury induced by ISO. In the heart of ISO injected rats the superoxide dismutase (SOD) was decreased but the contents of malondialdehyde (MDA) were increased. Pre-treatment with ocotillol could attenuate the changes of both SOD and MDA. The ISO-induced pathohistological changes were also ameliorated by ocotillo.
CONCLUSION: The findings suggested that ocotillol could have cardioprotective effects on myocardial injury induced by ISO in rats, which may be, in part, by virtue of enhancing the antioxidative potency of the heart.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17966755     DOI: 10.1055/s-0031-1296651

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  6 in total

1.  The Active Compounds of Yixin Ningshen Tablet and Their Potential Action Mechanism in Treating Coronary Heart Disease- A Network Pharmacology and Proteomics Approach.

Authors:  Xing Lv; Huijun Wang; Ruoming Wu; Xiaoyan Shen; Guan Ye
Journal:  Evid Based Complement Alternat Med       Date:  2020-01-25       Impact factor: 2.629

2.  (3R,6R,12R,20S,24S)-3,6,12-Triacetyl-20,24-ep-oxy-dammarane-3,6,12,25-tetra-ol.

Authors:  Huan-Mei Guo; Liang Wang; Nan Wang; Jiang-Feng Zhang; Qing-Guo Meng
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-12-11

3.  (3R,6R,12R,20S,24R)-20,24-Ep-oxy-dammarane-3,6,12,25-tetra-ol.

Authors:  Lei Zhang; Huan-Mei Guo; Wen-Juan Li; Yi-Jun Gao; Qing-Guo Meng
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-03-12

4.  (3R,6R,12R,20S,24S)-20,24-Ep-oxy-dammarane-3,6,12,25-tetraol dihydrate.

Authors:  Qing-Guo Meng; Lian-Dong Liu; Huan-Mei Guo; Yi Bi; Liang Wang
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-11-17

5.  (3S,12R,20S,24R)-20,24-Ep-oxy-dammarane-3,12,25-triol.

Authors:  Wen-Juan Li; Huan-Mei Guo; Chun-Mei Ji; Yi Bi; Qing-Guo Meng
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-07-23

6.  The pseudoginsenoside F11 ameliorates cisplatin-induced nephrotoxicity without compromising its anti-tumor activity in vivo.

Authors:  Hongbo Wang; Liang Kong; Jianqiao Zhang; Guohua Yu; Guangyao Lv; Fangxi Zhang; Xiaoguang Chen; Jingwei Tian; Fenghua Fu
Journal:  Sci Rep       Date:  2014-05-16       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.